Generic Name and Formulations:
Yellow fever vaccine live; for SC inj; contains sorbitol, gelatin; preservative-free;.
Sanofi Pasteur, Inc.
Indications for YF-VAX:
Yellow fever immunization.
Adults and Children:
Give at least 10 days before expected exposure; may repeat every 10yrs. <9 months: not recommended. ≥9 months: 0.5mL SC.
Infants <9 months of age. Severe egg allergy (consider skin test and desensitization; see literature). Immunodeficiency or risk of immunosuppression (eg, systemic corticosteroid therapy, chemotherapy, radiation). Thymic dysfunction.
Latex allergy. Have epinephrine (1:1000) available. Elderly (increased risk of systemic events; evaluate prior to, and monitor for at least 10 days after, vaccination). Pregnancy (Cat.C). Nursing mothers.
Concomitant vaccines: see literature.
Yellow fever vaccine.
Injection site reactions, rash, headache, malaise, myalgia, fever; rare neurotropic or viscerotropic disease.
Available only to Yellow Fever Vaccination Centers.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Intervention Improves Breast Cancer Survivors' Memory Contentment
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|